Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

MUCINEX® LAUNCHES GO ALL 12 CAMPAIGN TO POWER FANS THROUGH FOOTBALL SUNDAY, ALL SEASON LONG

Mucinex® 12HR Cold & Fever Multi-Symptom

News provided by

Mucinex

Oct 08, 2026, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Mucinex® and JoJo Fletcher Team Up to Spotlight Mucinex® 12HR Cold & Fever Multi-Symptom and its 12 Hours of Symptom Relief

  • For far too long, cold and flu season has forced consumers to focus on managing their symptoms instead of the plans and moments that matter most. Mucinex® is changing that with the new Mucinex® 12HR Cold & Fever Multi-Symptom, delivering long-lasting relief so they can stay focused on their day, not their symptoms.
  • Whether you're cheering in the stands or celebrating at a tailgate, this football season, Mucinex® is bringing that 12-hour relief to life through its new Go All 12 campaign, helping keep consumers gameday ready all season long.
  • Mucinex® is partnering with JoJo Fletcher to show fans that they can Go All 12 without letting cold and flu symptoms interrupt their gameday rituals.

NUTLEY, N.J., Oct. 8, 2026 /PRNewswire/ -- When cold and flu symptoms hit, consumers and football fans still have plans, traditions and rituals they don't want interrupted by the need to manage their symptoms. That consumer reality is at the heart of Mucinex® 12HR Cold & Fever Multi-Symptom, a new 12-hour relief option designed to help people spend less time managing their symptoms and more time staying in the moments that matter.

Mucinex® 12HR Cold & Fever Multi-Symptom
Mucinex® 12HR Cold & Fever Multi-Symptom
JoJo Fletcher and Mr. Mucus at Mucinex's Go All 12 Tailgate in Tampa, FL.
JoJo Fletcher and Mr. Mucus at Mucinex's Go All 12 Tailgate in Tampa, FL.

Unlike existing cold and flu medicines that leave consumers managing symptoms every 4-6 hours, Mucinex® 12HR Cold & Fever Multi-Symptom is a first-of-its-kind OTC medication designed to address the #1 unmet need in the cold and flu category—long-lasting symptom relief*—delivering 12 hours of relief in just one dose. With three times longer relief**, fans can stay focused on gameday from kickoff to the final whistle. It's a new 12-hour relief powerhouse designed for fans who refuse to miss a single moment.

"Cold and flu symptoms don't stick to a schedule, yet many medicines only provide four hours of relief — meaning symptoms can return, making it harder to show up for the moments that matter" said Henry Turgoose, Vice President of Marketing for Upper Respiratory at Reckitt. "For years, consumers have wanted longer-lasting symptom relief that helps them stay focused on their day, not their symptoms. With Mucinex® 12HR Cold & Fever Multi-Symptom, they can spend less time feeling their symptoms and more time staying fully engaged, from Football Sunday to everyday life."

To bring the product's all-day relief benefit to life, Mucinex® is launching "Go All 12," a new campaign inspired by one of the ultimate all-day occasions: Football Sunday. As part of the campaign, Mucinex® is teaming up with reality TV star, content creator, and entrepreneur JoJo Fletcher to show fans how they can Go All 12 without letting cold and flu symptoms interrupt their gameday traditions. As a busy working mom, wife of a former NFL player and devoted football fan, JoJo knows firsthand that cold and flu symptoms do not take a timeout on gameday.

"Jordan may not be playing anymore, but football Sundays are still an all-day event in our house," JoJo shared. "Between being a busy working mom, along with balancing Jordan's broadcasting schedule, gameday is one of those traditions we really look forward to as a family and I don't want cold and flu symptoms getting in the way. Mucinex® 12HR Cold & Fever Multi-Symptom gives me long-lasting relief so I can stay in the game all day long."

To bring the campaign into the action, JoJo Fletcher and Mucinex® hosted the Go All 12 Tailgate Experience in Tampa Bay on September 27. The activation brought football fans, media and influencers together for an immersive experience featuring branded giveaways, interactive games and exclusive VIP access.

The notorious Mr. Mucus crashed the tailgate, ready to buddy up with JoJo and Tampa fans, but to his surprise and thanks to new Mucinex® 12HR Cold & Fever Multi-Symptom, Mr. Mucus was sidelined from the fun. JoJo is now amplifying this run-in across her social channels throughout cold and flu season, showing fans how long-lasting symptom relief helps her stay in the game all day long.

In addition to the tailgate, the brand will partner with ESPN and Disney CreativeWorks on custom content featuring ESPN analyst Anthony "Booger" McFarland, integrating Mr. Mucus into football-centric storytelling across paid and owned channels. The campaign will also extend to DoorDash®, positioning Mucinex® 12HR Cold & Fever Multi-Symptom as the All-Day MVP with a special Football Sunday promotion, amplified through JoJo Fletcher, a lifestyle content creator and a social-first delivery featuring Mr. Mucus.

The fully integrated campaign includes:

  • Celebrity Partnership: Mucinex® partnered with reality TV star, content creator and entrepreneur JoJo Fletcher to bring "Go All 12" to life, sharing how she manages cold and flu symptoms while staying committed to her family's football traditions across earned, paid, and owned channels.
  • Tailgate Experience Activation: Mucinex® welcomed 400+ football fans to an interactive Go All 12 Tailgate Experience in Tampa Bay (September 27, 2026) hosted by JoJo Fletcher, bringing together media, influencers, and consumers for hands-on brand engagement.
  • Sports Media Integration: Mucinex® partnered with ESPN and Disney CreativeWorks on football-focused content featuring analyst Anthony "Booger" McFarland. As the presenting sponsor of NFL Primetime Presented by Mucinex, the brand is bringing its Go All 12 campaign to football fans across linear, streaming, digital, and social platforms.
  • Delivery Integration: Mucinex® partnered with DoorDash® to make Mucinex® 12HR Cold & Fever Multi-Symptom available nationwide, with fans receiving $2 off delivery from 11/1–12/3, while supplies last.
  • Brand Mascot Integration: Inspired by the rise of the Brand Mascot Era, Mucinex® is leveling up the role of Mr. Mucus this football season, bringing him into tailgates, stadiums, and living rooms—only to be sidelined for 12 hours when Mucinex® 12HR Cold & Fever Multi-Symptom enters the scene.
  • Retail Partnerships: Mucinex® will bring the campaign to life through in-store omnichannel activations at major retailers, including Walmart, Walgreens, and CVS Pharmacy.

Mucinex® 12HR Cold & Fever Multi-Symptom launched in 2026 and is a first-of-its-kind OTC medication designed to address the #1 unmet need in the cold and flu category —long-lasting symptom relief*— delivering up to 12 hours of relief in just one dose, addressing consumers' desire for longer-lasting symptom relief without needing to continually manage symptoms throughout the day. For more information on Mucinex® 12HR Cold & Fever Multi-Symptom, visit www.Mucinex.com, Walmart, Walgreens, and CVS Pharmacy.

About Mucinex® 

Mucinex® always has your back when cold and flu symptoms hit, offering a wide range of formulations that can help ease discomfort, day and night. Whether you're struggling with a nasty cough, unpleasant fever and sore throat or a nose that just won't stop running, the Mucinex® family of products provide relief you can trust when it's time to kick all your worst symptoms to the curb.

For more than 20 years, Mucinex® has provided consumers with world-class mucus and congestion relief, and it is #1 in more categories than you can imagine:

  • The #1 most trusted brand among physicians for cough and cold symptoms***
  • The #1 most trusted brand among respiratory specialists for cough and cold symptoms****
  • The #1 most trusted brand among physicians for their own family's cough & cold symptoms*****

For more information, visit Mucinex.com

About Reckitt®

Reckitt is a world-class consumer health and hygiene company on a mission to deliver better health in more hands, every day. Founded in 1840 in the United Kingdom, Reckitt is home to some of the world's most trusted and recognised brands across Germ Protection, Household Care, Intimate Wellness and Self Care, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet.

Operating in more than 80 countries, Reckitt sells approximately 30 million products every day and employs around 36,000 people worldwide. Through trusted brands, science-led innovation and deep consumer understanding, Reckitt helps make health, hygiene and wellbeing more accessible for millions of people while creating sustainable value for consumers, customers, communities and shareholders.

For more information, visit www.reckitt.com/us.

Reckitt is the trading name of the Reckitt group of companies

*Source: Clear C&F U&A 2022

**Compared to 1 dose of 4-hour medicine without re-dosing.

***IQVIA, ProVoice Survey, fielded to 3,930 physicians, September 1-December 31, 2024

****IQVIA, ProVoice Survey, fielded to 570 respiratory specialists, September 1-December 31, 2024

*****IQVIA, ProVoice Survey, fielded to 3,930 respiratory specialists, September 1-December 31, 2024

SOURCE Mucinex

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Mucinex + Artist Kurt Wenner to Debut Experiential 3D Art Exhibit in Grand Central Terminal - Week of 12/1

Mucinex + Artist Kurt Wenner to Debut Experiential 3D Art Exhibit in Grand Central Terminal - Week of 12/1

WHAT: To celebrate the launch of new Mucinex Clear & Cool Sinus Nasal Spray, Mucinex has teamed up with world-renowned artist Kurt Wenner to debut an ...

Mucinex® Introduces New Clear & Cool Sinus Nasal Spray, Delivering Instant Cooling Relief for Congestion

Mucinex® Introduces New Clear & Cool Sinus Nasal Spray, Delivering Instant Cooling Relief for Congestion

Mucinex, a Reckitt brand and the #1 physician-trusted cough and cold brand*, is expanding its portfolio with the launch of Mucinex Clear & Cool...

More Releases From This Source

Explore

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

General Sports

General Sports

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.